Not FDA-approved
Brain & sleep
Cerebrolysin
Evidence
Limited human data
Class
Mixture of peptides from pig brain tissue
KEY TAKEAWAY
Cerebrolysin is not a single peptide. It is a mixture of small peptides and amino acids made by breaking down pig brain proteins. Cerebrolysin is not FDA-approved. It is used in parts of Europe, Asia and Latin America.
Written by the Veylo editorial team · Updated
November 2026
What it is
Mixture of peptides from pig brain tissue
Main uses
Used in some countries after stroke or brain injury and in dementia
Key fact
Cerebrolysin is not FDA-approved. It is used in parts of Europe, Asia and Latin America.
Route
Injection or infusion
Evidence strength
Limited human data
Cerebrolysin is not a single peptide. It is a mixture of small peptides and amino acids made by breaking down pig brain proteins.
It is thought to mimic some effects of nerve growth factors and support nerve cell survival, although which components matter is not clear.
Cerebrolysin is not FDA-approved. It is used in parts of Europe, Asia and Latin America.
Used in some countries after stroke or brain injury and in dementia.
Reported effects include headache, dizziness and injection-related reactions. Trial evidence is mixed, and the product comes from animal tissue.
Cerebrolysin: see PubMed and ClinicalTrials.gov for published studies and registered trials. No FDA drug label exists for the uses described.
Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.